Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 253Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Introduction to real-world evidence studies

Chodankar Deepa

Year : 2021| Volume: 12| Issue : 3 | Page no: 171-174

   This article has been cited by
1 Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study
Wendyl D'Souza, Taoufik Alsaadi, Javier Montoya, Mar Carreño, Carlo Di Bonaventura, Rajiv Mohanraj, Takamichi Yamamoto, Rob McMurray, Oliver Shastri, Vicente Villanueva
Seizure. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome and other immune-mediated neurological diseases, over a 40-year experience
Mireya Fernández-Fournier, Ana Kerguelen, Francisco Javier Rodriguez de Rivera, Laura Lacruz, Santiago Jimeno, Itsaso Losantos-García, Dolores Hernández Maraver, Inmaculada Puertas, Antonio Tallon Barranco, Aurora Viejo, Ana Frank García, Exuperio Díez-Tejedor
Expert Review of Neurotherapeutics. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Using real-world data to extrapolate evidence from randomized controlled trials – experiences from Dubrava University Hospital
Ivana Jurin, Andela Jurišic, Šime Manola, Irzal Hadžibegovic
Cardiologia Croatica. 2022; 17(9-10): 271
[Pubmed]  [Google Scholar] [DOI]
4 The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Marlena van Munster, Johanne Stümpel, Franziska Thieken, Florin Ratajczak, Olivier Rascol, Margherita Fabbri, Timo Clemens, Katarzyna Czabanowska, Tiago A. Mestre, David J. Pedrosa
Journal of Parkinson's Disease. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
Patrick Maison, Mahmoud Zureik, Virginie Hivert, Jesper Kjaer, Roman Hossein Khonsari, Gianluca Trifirõ, Christelle Ratignier-Carbonneil
Frontiers in Pharmacology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
6 The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis
Jaime Fernández-Bravo-Rodrigo, Carlos Pascual-Morena, Amparo Flor-García, Alicia Saz-Lara, Irene Sequí-Dominguez, Celia Álvarez-Bueno, Dolores Barreda-Hernández, Iván Cavero-Redondo
International Journal of Environmental Research and Public Health. 2022; 19(3): 1753
[Pubmed]  [Google Scholar] [DOI]
7 A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from Two Prospective Studies
Vivian Valeska Lelleck, Franziska Schulz, Oliver Witt, Gianna Kühn, Dominik Klein, Astrid Gendolla, Stefan Evers, Charly Gaul, Diamant Thaçi, Christian Sina, Torsten Schröder
Nutrients. 2022; 14(14): 2927
[Pubmed]  [Google Scholar] [DOI]


Read this article